t-cells

Documents about t-cells

• Leveraging expression quantitative trait loci information in single-cell resolution to identify cell-specific genes for Basal cell carcinoma#428180PLOS
• Spatial colocalization of neoantigen-expressing tumor cells and cognate T cells in cancer#178271Ora Oxford University Research
• Tissue CD14(+)CD8(+)T-cells reprogrammed by myeloid cells and modulated by LPS#465506PubMed Central
• Phase Change Cells#623788DigitalCommons@USU
• Importance et potentiel thérapeutique d'un nouveau couple récepteur-ligand dans l'inhibition des lymphocytes T CD8 par les lymphocytes T régulateurs dans les tumeurs#301074HAL (France)
• Regulatory T cells and inflammatory bowel diseases#70266J-STAGE (Japan)
• Glial cells in neuropathic pain.#295107NCBI PubMed Central
• Distant antimestastatic effect of enterotropic colon cancer-derived a4b7+ CD8+ T cells#326171HAL (France)
• Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation#810191ClinicalTrials.gov
• CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy#140982ClinicalTrials.gov
• Synergistic immune interactions between T cells and natural killer cells in allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: current status and future directions#4679Europe PMC
• 3RD GENERATION GD2 SPECIFIC CHIMERIC ANTIGEN RECEPTOR TRANSDUCED AUTOLOGOUS NATURAL KILLER T-CELLS FOR NEUROBLASTOMA#800829ClinicalTrials.gov
• GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma#813071ClinicalTrials.gov
• Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma#839788ClinicalTrials.gov
• FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma#844553ClinicalTrials.gov
• Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia#918793ClinicalTrials.gov
• The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells#158237ClinicalTrials.gov
• Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant#869705ClinicalTrials.gov
• EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia#325286ClinicalTrials.gov
• A Multicenter Study of CAR-T Cells in Primary Ph+All#812891ClinicalTrials.gov
• STAT3 in T Cells: At The Crossroads of Inflammation and Cancer#858010ClinicalTrials.gov
• NY-ESO-1 T Cells in OG Cancer#67903ClinicalTrials.gov
• Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus#885481ClinicalTrials.gov
• Human Monocytes Differentiate into Dendritic Cells Subsets that Induce Anergic and Regulatory T Cells in Sepsis#311863HAL (France)
• Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation#353981HAL (France)
• Accurate quantification of spliced and unspliced transcripts for single-cell RNA sequencing with tidesurf#461616PLOS
• Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease#4654Europe PMC
• After the Impact: Investigating the Role of Regulatory T Cells in Human Traumatic Brain Injury and their Potential as Therapeutic Targets#417397Apollo
• LILRB4 STAR-T Cells in the Treatment of R/R AML/CMML#805504ClinicalTrials.gov
• NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors#877362ClinicalTrials.gov
• Chimeric Autoantibody Receptor T Cells For Targeted Depletion Of Myeloperoxidase-Specific Anti-Neutrophil Cytoplasmic Antibody-Producing B Cells#929287ScholarlyCommons
• Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal Carcinoma#195322ClinicalTrials.gov
• 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3#888649ClinicalTrials.gov
• Low-dose IL-2 Treatment on Behcet's Disease#812544ClinicalTrials.gov
• γδ T cells control humoral immune response by inducing T follicular helper cell differentiation#654319Repositório Institucional da UFMG
• Programming T cells for intercellular genome editing#390867bioRxiv / medRxiv
• Systemic Sclerosis and Innate T Cells#843489ClinicalTrials.gov
• Engineered T cells achieve durable persistence in the brain by clearing a state-selective checkpoint that governs neuroimmune privilege#651690eScholarship
• Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies#831781ClinicalTrials.gov
• Characterization of Autoreactive Regulatory and Conventional CD4 T Cells in Recent Onset Type 1 Diabetes and Control Individuals#896688ClinicalTrials.gov
• Temporal dynamics of immune effector cell‐associated haematotoxicity: Linking early and late cytopenias after chimeric antigen receptor T cells#1000656HAL (France)
• Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer#902360ClinicalTrials.gov
• Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging#236528PLOS
• T cell Immunomodulation in the Lymph Node for Inhibition of Load-Induced Osteoarthritis#493650Cornell eCommons
• Distinct postnatal trajectories of mouse dendritic epidermal T cells and Langerhans cells independent of microbiota#661811Deutsche Nationalbibliothek
• Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells#802877ClinicalTrials.gov
• Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL#969175ClinicalTrials.gov
• T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma#875562ClinicalTrials.gov
• The Immune Base of Endometriosis#805335ClinicalTrials.gov
• CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)#268013ClinicalTrials.gov